| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $117.3B | $125.1B | $131.8B | $159.6B | $110.8B | $65.7B | $103.5B | $111.4B |
| Gross Profit | — | — | — | — | — | $-0.2B | $2.0B | $1.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.2B | $3.8B | $11.9B | $15.7B | $2.1B | $-0.5B | $1.7B | $1.3B |
| Net Income | $2.3B | $2.8B | $8.8B | $11.5B | $0.9B | $-0.4B | $1.1B | $1.0B |
| EPS (Basic) | $7.57 | $8.58 | $24.93 | $29.05 | $2.27 | $-0.88 | $2.58 | $2.26 |
| EPS (Diluted) | $7.57 | $8.58 | $24.92 | $29.04 | $2.27 | $-0.88 | $2.58 | $2.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $58.0B | $60.1B | $63.1B | $61.0B | $57.9B | $51.8B | $53.9B | $50.2B |
| Current Assets | $23.2B | $23.7B | $26.2B | $24.1B | $21.2B | $15.8B | $19.0B | $17.7B |
| Cash & Equivalents | $4.7B | $4.7B | $5.4B | $4.9B | $4.1B | $3.3B | $2.6B | $3.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $14.1B | $15.5B | $16.8B | $17.5B | $16.9B | $9.3B | $13.2B | $10.7B |
| Stockholders' Equity | $23.7B | $24.5B | $26.3B | $23.6B | $18.4B | $18.8B | $21.8B | $21.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.8B | $6.7B | $9.2B | $12.6B | $5.9B | $0.9B | $5.5B | $4.4B |
| Investing Cash Flow | $-1.8B | $-2.0B | $-1.9B | $-2.8B | $-2.2B | $-2.4B | $-3.0B | $-3.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.2B | $-5.0B | $-6.9B | $-8.8B | $-2.8B | $2.1B | $-3.0B | $-3.2B |